Venture Capital

Protaryx Medical Announces $8.3M In Funding For First-class Technology For Left Atrial Access In Transcatheter Cardiac Procedures | Business Wire

by posted 7months ago 354 views
BALTIMORE--(BUSINESS WIRE)--Protaryx™ Medical, a company committed to reimagining access to the left atrium for transcatheter cardiac procedures, today announced that it has raised $8.3 million in funding to develop the company’s first-in-class device for precision transseptal access to the left atrium during structural heart and catheter ablation procedures. The company’s funding includes non-dilutive grants and a seed round totaling $3.2 million and the recently closed $5.1M Series A financin.